Northwestern Mutual Wealth Management
RAPT

Northwestern Mutual Wealth Management’s RAPT Therapeutics RAPT Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2
Closed – – 3342
2022
Q2 		$0 Hold
2
– – ﹤0.01% 3421
2022
Q1 		$0 Buy
+2
New +$378 ﹤0.01% 3343

Other funds holding RAPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Northwestern Mutual Wealth Management's RAPT Position: Q3 2022 in Review

Northwestern Mutual Wealth Management sold out of RAPT Therapeutics (RAPT) in Q3 2022, closing a stake of 2 shares.

Northwestern Mutual Wealth Management first reported a position in RAPT in Q1 2022 and held it in 2 quarters. The position peaked at $0 in Q2 2022. 98 funds tracked by Wall St. Rank hold RAPT as of Q3 2022.

  • Northwestern Mutual Wealth Management reported no remaining RAPT Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 2 RAPT Therapeutics shares in Q3 2022.
  • Northwestern Mutual Wealth Management first reported a position in RAPT Therapeutics in Q1 2022 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's RAPT Therapeutics position peaked at $0 in Q2 2022.
  • 98 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q3 2022.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.